BIOMARIN PHARMACEUTICAL INC - 8-K Filing
BioMarin's stockholders approved an amendment to the 2017 Equity Incentive Plan at their May 2, 2026 annual meeting, increasing share reserves by 7.65 million shares. The vote results showed strong support for all ten director nominees and ratification of KPMG as auditor; compensation approval received 83% in favor. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $BMRN